top of page
_edited.png)
Asset # | Therapeutic Area | Target | Stage of Development |
|---|---|---|---|
SG1030 | Oncology | KRAS G12D | Preclinical |
SG1062 | NASH | THF-b, FXR, GLP1 | Phase 1 & Phase 2 |
SG1063 | Oncology | FAK/SRC | IND Ready |
SG1064 | Diabetes/Obesity | GLP1 | Oral IND ready |
SG1065 | IPF | Smoothened | IND Ready |
SG1066 | Oncology | G12D | Phase 1 |
SG1067 | Oncology | Brain Penetrable BTK | Phase 2 |
SG1068 | Oncology | Pan-KRAS | Preclinical |
SG1069 | Pain | Nav1.8 | Phase 1 |
Asset Portfolio
bottom of page